Hemispherian raises the first tranche of a Series A to fund the development of its novel cancer therapeutics
Read More
Hemispherian Secures EUR 10M in Financing from the European Innovation Council (EIC) Accelerator Program
Hemispherian raises seed funding for novel cancer therapeutics
World Leaders in Brain Cancer Join Hemispherian’s Clinical Advisory Board, Chaired by Dr. Roger Stupp
Hemispherian is delighted to announce its first granted patent
Hemispherian completes its seed financing and appoints Masha Strømme as Chair of the Board
Josipa Matic joins Hemispherian as Medicinal chemist. Welcome!